rs2292195

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004517.4(ILK):​c.918C>T​(p.Ala306Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.246 in 1,613,950 control chromosomes in the GnomAD database, including 50,360 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 3906 hom., cov: 33)
Exomes 𝑓: 0.25 ( 46454 hom. )

Consequence

ILK
NM_004517.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.550

Publications

21 publications found
Variant links:
Genes affected
ILK (HGNC:6040): (integrin linked kinase) This gene encodes a protein with a kinase-like domain and four ankyrin-like repeats. The encoded protein associates at the cell membrane with the cytoplasmic domain of beta integrins, where it regulates integrin-mediated signal transduction. Activity of this protein is important in the epithelial to mesenchymal transition, and over-expression of this gene is implicated in tumor growth and metastasis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]
TAF10 (HGNC:11543): (TATA-box binding protein associated factor 10) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the small subunits of TFIID that is associated with a subset of TFIID complexes. Studies with human and mammalian cells have shown that this subunit is required for transcriptional activation by the estrogen receptor, for progression through the cell cycle, and may also be required for certain cellular differentiation programs. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 11-6609785-C-T is Benign according to our data. Variant chr11-6609785-C-T is described in ClinVar as Benign. ClinVar VariationId is 137591.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.55 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.257 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004517.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ILK
NM_004517.4
MANE Select
c.918C>Tp.Ala306Ala
synonymous
Exon 10 of 13NP_004508.1Q13418-1
TAF10
NM_006284.4
MANE Select
c.*1137G>A
3_prime_UTR
Exon 5 of 5NP_006275.1Q12962
ILK
NM_001014794.3
c.918C>Tp.Ala306Ala
synonymous
Exon 10 of 13NP_001014794.1Q13418-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ILK
ENST00000299421.9
TSL:1 MANE Select
c.918C>Tp.Ala306Ala
synonymous
Exon 10 of 13ENSP00000299421.4Q13418-1
ILK
ENST00000396751.6
TSL:1
c.918C>Tp.Ala306Ala
synonymous
Exon 9 of 12ENSP00000379975.2Q13418-1
ILK
ENST00000420936.6
TSL:1
c.918C>Tp.Ala306Ala
synonymous
Exon 10 of 13ENSP00000403487.2Q13418-1

Frequencies

GnomAD3 genomes
AF:
0.218
AC:
33089
AN:
151968
Hom.:
3903
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.151
Gnomad AMI
AF:
0.139
Gnomad AMR
AF:
0.214
Gnomad ASJ
AF:
0.250
Gnomad EAS
AF:
0.101
Gnomad SAS
AF:
0.161
Gnomad FIN
AF:
0.294
Gnomad MID
AF:
0.203
Gnomad NFE
AF:
0.260
Gnomad OTH
AF:
0.223
GnomAD2 exomes
AF:
0.228
AC:
57404
AN:
251478
AF XY:
0.226
show subpopulations
Gnomad AFR exome
AF:
0.147
Gnomad AMR exome
AF:
0.237
Gnomad ASJ exome
AF:
0.253
Gnomad EAS exome
AF:
0.107
Gnomad FIN exome
AF:
0.298
Gnomad NFE exome
AF:
0.257
Gnomad OTH exome
AF:
0.238
GnomAD4 exome
AF:
0.249
AC:
363420
AN:
1461864
Hom.:
46454
Cov.:
42
AF XY:
0.247
AC XY:
179468
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.142
AC:
4747
AN:
33480
American (AMR)
AF:
0.236
AC:
10561
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.248
AC:
6491
AN:
26134
East Asian (EAS)
AF:
0.124
AC:
4915
AN:
39700
South Asian (SAS)
AF:
0.163
AC:
14045
AN:
86256
European-Finnish (FIN)
AF:
0.292
AC:
15595
AN:
53416
Middle Eastern (MID)
AF:
0.212
AC:
1220
AN:
5764
European-Non Finnish (NFE)
AF:
0.263
AC:
291935
AN:
1111994
Other (OTH)
AF:
0.230
AC:
13911
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
17632
35264
52897
70529
88161
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9764
19528
29292
39056
48820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.218
AC:
33100
AN:
152086
Hom.:
3906
Cov.:
33
AF XY:
0.216
AC XY:
16094
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.151
AC:
6255
AN:
41488
American (AMR)
AF:
0.214
AC:
3268
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
869
AN:
3472
East Asian (EAS)
AF:
0.101
AC:
524
AN:
5176
South Asian (SAS)
AF:
0.161
AC:
775
AN:
4820
European-Finnish (FIN)
AF:
0.294
AC:
3107
AN:
10580
Middle Eastern (MID)
AF:
0.204
AC:
60
AN:
294
European-Non Finnish (NFE)
AF:
0.260
AC:
17648
AN:
67952
Other (OTH)
AF:
0.221
AC:
467
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1321
2641
3962
5282
6603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.242
Hom.:
3424
Bravo
AF:
0.210
Asia WGS
AF:
0.148
AC:
516
AN:
3478
EpiCase
AF:
0.257
EpiControl
AF:
0.254

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
1
not provided (1)
-
-
1
Primary familial hypertrophic cardiomyopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
12
DANN
Benign
0.88
PhyloP100
0.55
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2292195; hg19: chr11-6631016; COSMIC: COSV54989926; COSMIC: COSV54989926; API